Xin Guan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xin Guan has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Hui-Xiong Xu
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, China
3 shared publications Xiaolong Li
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, P. R. China
3 shared publications- Haohao Yin
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, China
2 shared publications Lizhou Lin
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, P. R. China
2 shared publicationsXiao Li
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, P. R. China
2 shared publicationsYuting Shen
Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, P. R. China
2 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Low-intensity focused ultrasound-activated piezoelectric gel bandage for diabetic wound repair and neuropathic pain relief
Nociceptive hypersensitivity and prolonged wound healing due to the interaction of peripheral neuropathy and local immune disorders are key issues that need to be addressed in diabetic foot ulcer (DFU) regenerative repair. Here, we present a low-intensity focused ultrasound (LIFU)-activated piezoelectric gel bandage for DFU wound repair and neuropathic pain relief. Acting as an artificial “skin”, this self-powered, functionalized bandage not only temporarily shields tissue from external environment, but also serves as a drug reservoir that can in situ release nitric oxide upon LIFU to promote macrophage polarization, generate piezoelectric current to desensitize TRPV1 nociceptor for on demand neuropathic pain relief and produce reactive oxygen species to eliminate pathogens in male rodents. More importantly, this regimen can promote CGRP neuropeptides release from sensory neurons to invigorate M2-like macrophages-mediated protective cutaneous immunity. This LIFU-activated immune-nociceptor modulation strategy is potentially applicable to other non-healing tissue regeneration.
- 19 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessLow-intensity focused ultrasound-activated piezoelectric gel bandage for diabetic wound repair and neuropathic pain relief
Nociceptive hypersensitivity and prolonged wound healing due to the interaction of peripheral neuropathy and local immune disorders are key issues that need to be addressed in diabetic foot ulcer (DFU) regenerative repair. Here, we present a low-intensity focused ultrasound (LIFU)-activated piezoelectric gel bandage for DFU wound repair and neuropathic pain relief. Acting as an artificial “skin”, this self-powered, functionalized bandage not only temporarily shields tissue from external environment, but also serves as a drug reservoir that can in situ release nitric oxide upon LIFU to promote macrophage polarization, generate piezoelectric current to desensitize TRPV1 nociceptor for on demand neuropathic pain relief and produce reactive oxygen species to eliminate pathogens in male rodents. More importantly, this regimen can promote CGRP neuropeptides release from sensory neurons to invigorate M2-like macrophages-mediated protective cutaneous immunity. This LIFU-activated immune-nociceptor modulation strategy is potentially applicable to other non-healing tissue regeneration.
- Open Access
- 26 May 2025
- Published by Springer Nature in Research Square
LIFUS-Driven Engineered Bacteria Reprogram Immunosuppressive Niches via Mechano-NOTCH Signaling
The tumor microenvironment (TME) of solid tumors constructs a complex biophysical barrier with intricate interactions, including dense stromal structures and immunosuppressive networks, which severely limit the permeability and efficacy of immunotherapy. This study developed an engineered an attenuated Salmonella typhimurium VNP20009 strain encoding an acoustic reporter gene (ARG)-based gas vesicles (GVs), enabling real-time tumor imaging guided mechano-immunomodulation. Low-intensity focused ultrasound (LIFUS) triggered cavitation effects from GVs, generating localized shear forces and mechanical strain. This significantly inhibited tumor growth and attenuated the NOTCH-mediated crosstalk between cancer-associated fibroblasts (CAFs) and CD8⁺ T cells, thereby relieving CD8⁺ T cell activity. This mechanobiological intervention elicited a 12-fold enhancement in cytotoxic CD8⁺ T cell infiltration and extended median survival to over 60 days (versus 30-40 days in controls) in aggressive murine tumor models, demonstrating significant therapeutic efficacy. This integrated strategy establishes a closed-loop therapeutic platform combining bacterial targeting, acoustic visualization, and LIFUS-driven mechano-immunomodulation, achieving 92.7% suppression of both primary and metastatic tumor growth. By synergizing synthetic biology with mechano-immunological regulation, our study pioneers a precisely controllable and real-time image-monitored therapeutic paradigm, providing a transformative approach to overcome solid tumor resistance and accelerate clinical translation.
- 26 May 2025
- Published by Springer Nature in Research Square
Open AccessLIFUS-Driven Engineered Bacteria Reprogram Immunosuppressive Niches via Mechano-NOTCH Signaling
The tumor microenvironment (TME) of solid tumors constructs a complex biophysical barrier with intricate interactions, including dense stromal structures and immunosuppressive networks, which severely limit the permeability and efficacy of immunotherapy. This study developed an engineered an attenuated Salmonella typhimurium VNP20009 strain encoding an acoustic reporter gene (ARG)-based gas vesicles (GVs), enabling real-time tumor imaging guided mechano-immunomodulation. Low-intensity focused ultrasound (LIFUS) triggered cavitation effects from GVs, generating localized shear forces and mechanical strain. This significantly inhibited tumor growth and attenuated the NOTCH-mediated crosstalk between cancer-associated fibroblasts (CAFs) and CD8⁺ T cells, thereby relieving CD8⁺ T cell activity. This mechanobiological intervention elicited a 12-fold enhancement in cytotoxic CD8⁺ T cell infiltration and extended median survival to over 60 days (versus 30-40 days in controls) in aggressive murine tumor models, demonstrating significant therapeutic efficacy. This integrated strategy establishes a closed-loop therapeutic platform combining bacterial targeting, acoustic visualization, and LIFUS-driven mechano-immunomodulation, achieving 92.7% suppression of both primary and metastatic tumor growth. By synergizing synthetic biology with mechano-immunological regulation, our study pioneers a precisely controllable and real-time image-monitored therapeutic paradigm, providing a transformative approach to overcome solid tumor resistance and accelerate clinical translation.
- Open Access
- 20 May 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Cancer recurrence after surgical resection (SR) is a considerable challenge, and the biological effect of SR on the tumor microenvironment (TME) that is pivotal in determining postsurgical treatment efficacy remains poorly understood. Here, with an experimental model, we demonstrate that the genomic landscape shaped by SR creates an immunosuppressive milieu characterized by hypoxia and high-influx of myeloid cells, fostering cancer progression and hindering PD-L1 blockade therapy. To address this issue, we engineer a radio-immunostimulant nanomedicine (IPI549@HMP) capable of targeting myeloid cells, and catalyzing endogenous H2O2 into O2 to achieve hypoxia-relieved radiotherapy (RT). The enhanced RT-mediated immunogenic effect results in postsurgical TME reprogramming and increased susceptibility to anti-PD-L1 therapy, which can suppress/eradicate locally residual and distant tumors, and elicits strong immune memory effects to resist tumor rechallenge. Our radioimmunotherapy points to a simple and effective therapeutic intervention against postsurgical cancer recurrence and metastasis.
- 20 May 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessNanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Cancer recurrence after surgical resection (SR) is a considerable challenge, and the biological effect of SR on the tumor microenvironment (TME) that is pivotal in determining postsurgical treatment efficacy remains poorly understood. Here, with an experimental model, we demonstrate that the genomic landscape shaped by SR creates an immunosuppressive milieu characterized by hypoxia and high-influx of myeloid cells, fostering cancer progression and hindering PD-L1 blockade therapy. To address this issue, we engineer a radio-immunostimulant nanomedicine (IPI549@HMP) capable of targeting myeloid cells, and catalyzing endogenous H2O2 into O2 to achieve hypoxia-relieved radiotherapy (RT). The enhanced RT-mediated immunogenic effect results in postsurgical TME reprogramming and increased susceptibility to anti-PD-L1 therapy, which can suppress/eradicate locally residual and distant tumors, and elicits strong immune memory effects to resist tumor rechallenge. Our radioimmunotherapy points to a simple and effective therapeutic intervention against postsurgical cancer recurrence and metastasis.